BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10450377)

  • 1. Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes.
    Warpeha KM; Ah-Fat F; Harding S; Patterson CC; Xu W; Hart PM; Chakravarthy U; Hughes AE
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():174-8. PubMed ID: 10450377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.
    Demaine A; Cross D; Millward A
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4064-8. PubMed ID: 11095596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
    Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
    Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy.
    Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Kamoi K; Ito S
    Horm Metab Res; 2000 Feb; 32(2):80-3. PubMed ID: 10741691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
    Mansfield MW; Stickland MH; Carter AM; Grant PJ
    Thromb Haemost; 1994 Jun; 71(6):731-6. PubMed ID: 7974340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphic markers of the NO synthase genes and genetic predisposition to diabetic polyneuropathy in patients with type 1 diabetes mellitus].
    Zotova EV; Voron'ko OE; Bursa TR; Galeev IV; Strokov IA; Nosikov VV
    Mol Biol (Mosk); 2005; 39(2):224-9. PubMed ID: 15856945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):542-6. PubMed ID: 17973941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India.
    Uthra S; Raman R; Mukesh BN; Padmaja Kumari R; Paul PG; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
    Ophthalmic Genet; 2007 Jun; 28(2):77-81. PubMed ID: 17558849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms in association with diabetic retinopathy susceptibility: a meta-analysis.
    Zhao S; Li T; Zheng B; Zheng Z
    Ophthalmic Genet; 2012 Dec; 33(4):200-7. PubMed ID: 22506535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.
    Riener EK; Hefler LA; Grimm C; Galid A; Zeillinger R; Tong-Cacsire D; Gitsch G; Leodolter S; Tempfer CB
    Gynecol Oncol; 2004 Jun; 93(3):686-90. PubMed ID: 15196865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy.
    Taverna MJ; Sola A; Guyot-Argenton C; Pacher N; Bruzzo F; Slama G; Reach G; Selam JL
    Diabetologia; 2002 Mar; 45(3):436-42. PubMed ID: 11914750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjects.
    Manea SA; Robciuc A; Guja C; Heltianu C
    Biochem Biophys Res Commun; 2011 Apr; 407(3):486-90. PubMed ID: 21406182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy.
    Bregar D; Cilenšek I; Mankoč S; Reschner A; Petrovič D; Globočnik Petrovič M
    Bosn J Basic Med Sci; 2018 Feb; 18(1):80-86. PubMed ID: 28817788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.
    Beránek M; Kanková K; Benes P; Izakovicová-Hollá L; Znojil V; Hájek D; Vlková E; Vácha J
    Am J Med Genet; 2002 May; 109(4):278-83. PubMed ID: 11992481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes.
    Sivenius K; Niskanen L; Voutilainen-Kaunisto R; Laakso M; Uusitupa M
    Diabet Med; 2004 Dec; 21(12):1325-33. PubMed ID: 15569136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase gene polymorphisms and diabetic nephropathy.
    Rippin JD; Patel A; Belyaev ND; Gill GV; Barnett AH; Bain SC
    Diabetologia; 2003 Mar; 46(3):426-8. PubMed ID: 12687343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.